Suchergebnisse - "Antoniadou, Anastasia"

PubPharm (10)

1

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome : a randomized clinical trial

enthalten in: Critical care (London, England) | 2022

von Karakike, E. | Scicluna, B. | Roumpoutsou, M. | +25

CommentIn: Crit Care. 2022 Aug 5;26(1):238. - PMID 35932059

2

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial

enthalten in: Lancet (London, England) | 2022

von ITAC (INSIGHT 013) Study Group | Polizzotto, M. | Nordwall, J. | +86

3

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial

enthalten in: American journal of respiratory and critical care medicine | 2021

von Kyriazopoulou, E. | Liaskou-Antoniou, L. | Adamis, G. | +24

CommentIn: Am J Respir Crit Care Med. 2021 Jan 15;203(2):157-158. - PMID 32936687

4

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Dickstein, Y. | Lellouche, J. | Schwartz, D. | +71

5

Colistin plus meropenem for carbapenem-resistant Gram-negative infections : in vitro synergism is not associated with better clinical outcomes

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020

von Nutman, A. | Lellouche, J. | Temkin, E. | +67

CommentIn: Clin Microbiol Infect. 2020 Sep;26(9):1274. - PMID 32389843

6

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections : An Exploratory Subgroup Analysis of a Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Dickstein, Y. | Lellouche, J. | Ben Dalak Amar, M. | +65

CommentIn: Clin Infect Dis. 2020 Aug 22;71(5):1358-1359. - PMID 31734694

7

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria : A Prospective Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2018

von Zak-Doron, Y. | Dishon Benattar, Y. | Pfeffer, I. | +63

8

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria : an open-label, randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Paul, M. | Daikos, G. | Durante-Mangoni, E. | +24

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):358-360. - PMID 29456042

9

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA) : a study protocol

enthalten in: BMJ open | 2016

von Dickstein, Y. | Leibovici, L. | Yahav, D. | +22

10

The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality : an observational cohort study

enthalten in: Critical care medicine | 2015

von Dautzenberg, M. | Wekesa, A. | Gniadkowski, M. | +91

CommentIn: Crit Care Med. 2015 Nov;43(11):e536-7. - PMID 26468729

1
[1]